Detalhe da pesquisa
1.
Real-world use of ofatumumab to treat multiple sclerosis 9 months post-FDA approval during COVID-19 pandemic.
Mult Scler Relat Disord
; 78: 104881, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556938